Stay updated with breaking news from Small Molecules. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lonza Group AG / Key word(s): ExpansionLonza Announces New Filling Line for Commercial Supply of Antibody-Drug Conjugates for a Dedicated Customer 13.10.2023 / 08:00 CET/CEST The new cGMP filling line at Lonza’s Stein (CH) site will enable handling and filling of bioconjugates for commercial supply Expansion of fill...
We spoke to Professor Janet Hemingway, founding Director of iiCON and Professor of Tropical Medicine at Liverpool School of Tropical Medicine.
Lonza Group AG (OTCMKTS:LZAGY – Get Free Report) shares reached a new 52-week low on Tuesday . The company traded as low as $44.77 and last traded at $44.97, with a volume of 86933 shares. The stock had previously closed at $45.67. Analyst Upgrades and Downgrades Separately, HSBC assumed coverage on Lonza Group in a […]
PharmAla has recieved a positive First Office Action on its novel P-1 Molecule from the Patent Cooperation Treaty...
PCT Examiner Finds Molecule to be both Novel and Inventive VANCOUVER, British Columbia, Sept. 25, 2023 -- PharmAla Biotech Holdings Inc. , a biotechnology company focused on the research,...